Editor - Ahmed Lasfar | Cancer Center-University Hospital | 4503
ISSN: 2157-2526

Journal of Bioterrorism & Biodefense
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 457

Journal of Bioterrorism & Biodefense received 457 citations as per google scholar report

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Ahmed Lasfar

Ahmed Lasfar
Ahmed Lasfar
Department of Biochemistry and Molecular Biology
Cancer Center-University Hospital
UMDNJ-New Jersey Medical School


Dr. Ahmed Lasfar is a Researcher, working on improving the use of Interferon in cancer and determining the mechanisms of resistance to interferon therapy, at the University Hospital Cancer Center, New Jersey Medical School/University of Medicine and Dentistry of New Jersey. He is a member of the Department of Biochemistry and Molecular Biology at NJMS/UMDNJ. He has completed his Post-Doctoral training (1999-2002) in the Department of Molecular Genetics, Microbiology and Immunology at Robert Wood Johnson Medical School, UMDNJ, under the supervision of Dr. Sidney Pestka (Leader for the approval of IFN use in Clinic, by the FDA in 1986 and the winner of the National Medal of Technology in 2002). Dr. Ahmed lasfar has received a PhD in Immunology from Paris University of Science, France in 1996. He has completed his Master Degree in Rene Descartes University, School of Medicine, France (1992). He received several awards, including two excellence scientific awards from the New Jersey Commission on Cancer Research and one award from the International Society for Interferon and Cytokine Research.

Research Interest

Interferon lambda signaling in normal and cancer cells, Strategies for the improvement of interferon treatment in melanoma, Role of Interferon lambdas in Hepatocelluar Carcinoma, Mechanisms of TGF beta resistance, Interaction between TGF beta and Interferons.



Global Speakers in the subject

Global Experts in the subject